These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 3028701)
1. Lack of angiotensin I accumulation after converting enzyme blockade by enalapril or lisinopril in man. Nussberger J; Brunner DB; Waeber B; Biollaz J; Brunner HR Clin Sci (Lond); 1987 Mar; 72(3):387-9. PubMed ID: 3028701 [TBL] [Abstract][Full Text] [Related]
2. Effects on plasma angiotensin-converting enzyme activity and circulating renin of lisinopril and enalapril alone and in combination with propranolol in healthy volunteers. Hansen EF; Bendtsen F; Henriksen JH Pharmacol Toxicol; 1999 Mar; 84(3):110-4. PubMed ID: 10193670 [TBL] [Abstract][Full Text] [Related]
3. A comparison of lisinopril with enalapril by monitoring plasma angiotensin II levels in humans. Kawamura M; Imanishi M; Matsushima Y; Akabane S; Kuramochi M; Ito K; Omae T Jpn J Pharmacol; 1990 Oct; 54(2):143-9. PubMed ID: 1963909 [TBL] [Abstract][Full Text] [Related]
4. Acute hemodynamic and hormonal effects of lisinopril (MK-521) in congestive heart failure. Dickstein K; Aarsland T; Woie L; Abrahamsen AM; Fyhrquist F; Cummings S; Gomex HJ; Hagen E; Kristianson K Am Heart J; 1986 Jul; 112(1):121-9. PubMed ID: 3014850 [TBL] [Abstract][Full Text] [Related]
5. Increase in vasoactive intestinal polypeptides (VIP) by the angiotensin converting enzyme (ACE) inhibitor lisinopril in congestive heart failure. Relation to haemodynamic and hormonal changes. Woie L; Dickstein K; Kaada B Gen Pharmacol; 1987; 18(6):577-87. PubMed ID: 2822521 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril. Nussberger J; Wuerzner G; Jensen C; Brunner HR Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102 [TBL] [Abstract][Full Text] [Related]
7. Additive effects of losartan and enalapril on blood pressure and plasma active renin. Azizi M; Guyene TT; Chatellier G; Wargon M; Ménard J Hypertension; 1997 Feb; 29(2):634-40. PubMed ID: 9040450 [TBL] [Abstract][Full Text] [Related]
8. Measurement of angiotensin converting enzyme induction and inhibition using quantitative in vitro autoradiography: tissue selective induction after chronic lisinopril treatment. Kohzuki M; Johnston CI; Chai SY; Jackson B; Perich R; Paxton D; Mendelsohn FA J Hypertens; 1991 Jul; 9(7):579-87. PubMed ID: 1653792 [TBL] [Abstract][Full Text] [Related]
9. Investigation of the biochemical effects of renin inhibition in normal volunteers treated by an ACE inhibitor. Chauveau D; Guyenne TT; Cumin F; Chatellier G; Corvol P; Ménard J Br J Clin Pharmacol; 1992 Mar; 33(3):253-60. PubMed ID: 1315560 [TBL] [Abstract][Full Text] [Related]
10. Effects of the angiotensin converting enzyme inhibitor, lisinopril, on normal and diabetic rats. Hartmann JF; Szemplinski M; Hayes NS; Keegan ME; Slater EE J Hypertens; 1988 Aug; 6(8):677-83. PubMed ID: 2846685 [TBL] [Abstract][Full Text] [Related]
11. The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition. Keuneke C; Yacullo R; Metzger R; Hellmann T; Peters J; Ganten D Eur Heart J; 1990 May; 11 Suppl D():11-6. PubMed ID: 2163328 [TBL] [Abstract][Full Text] [Related]
12. Lisinopril and nifedipine: no acute interaction in normotensives. Lees KR; Reid JL Br J Clin Pharmacol; 1988 Mar; 25(3):307-13. PubMed ID: 2833920 [TBL] [Abstract][Full Text] [Related]
13. Hemodynamic responses to converting enzyme inhibition in patients with renal disease. August P; Cody RJ; Sealey JE; Laragh JH Am J Hypertens; 1989 Aug; 2(8):599-603. PubMed ID: 2550029 [TBL] [Abstract][Full Text] [Related]
14. Direct radio-immunoassay of renin substrate: effect of converting enzyme inhibition. Metsärinne K; Rosenlöf K; Grönhagen-Riska C; Fyhrquist F Scand J Clin Lab Invest; 1988 Apr; 48(2):131-6. PubMed ID: 2833813 [TBL] [Abstract][Full Text] [Related]
15. Hemodynamic, hormonal, and pharmacokinetic aspects of treatment with lisinopril in congestive heart failure. Dickstein K J Cardiovasc Pharmacol; 1987; 9 Suppl 3():S73-81. PubMed ID: 2442558 [TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE? Schilders JE; Wu H; Boomsma F; van den Meiracker AH; Danser AH Cardiovasc Drugs Ther; 2014 Aug; 28(4):335-45. PubMed ID: 24958603 [TBL] [Abstract][Full Text] [Related]
17. Different hemodynamic (24-h ambulatory blood pressure monitoring) and renin-inhibiting effect of a 1-week treatment with enalapril and lisinopril. Cocco G; Hari J Clin Cardiol; 1991 Nov; 14(11):881-4. PubMed ID: 1662562 [TBL] [Abstract][Full Text] [Related]
18. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition. Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI Am J Med; 1984 Aug; 77(2A):52-60. PubMed ID: 6089557 [TBL] [Abstract][Full Text] [Related]
19. Pharmacology of angiotensin converting enzyme inhibitors. A review. Nelson EB; Pool JL; Taylor AA Am J Med; 1986 Oct; 81(4C):13-8. PubMed ID: 3022580 [TBL] [Abstract][Full Text] [Related]
20. Onset of action of captopril, enalapril, enalaprilic acid and lisinopril in normal man. Semple PF; Cumming AM; Meredith PA; Morton JJ Cardiovasc Drugs Ther; 1987; 1(1):45-50. PubMed ID: 2856460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]